| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
|
Still deciding? Get samples of US$ 300/gram
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
A series of clinical studies have demonstrated that inhibition of IL-6 signaling by tocilizumab is highly effective in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, giant lymph node hyperplasia, and Crohn's disease. In these diseases, tocilizumab slows down the clinical manifestations of inflammation and returns acute phase protein levels to normal. tochemicalbookocilizumab is well tolerated whether administered as a single agent or in combination (e.g., with methotrexate). tocilizumab significantly reduces the number of invading capillaries in tumors. Otherwise, tocilizumab had no effect on the rate of mitosis and apoptosis of tumor cells.
| Product Name | TocilizuMab |
| Synonyms | TocilizuMab;Actemra;Actemra 200;anti-IL-6R Tocilizumab;Atlizumab;R 1569;RoActemra;Tocilizumab,Atlizumab |
| MOQ | 1kg |
| CAS | 375823-41-9 |
| Appearance | white |
| Molecular Formula | C14H12O3 |
| Molecular Weight | 0 |
| Assay | >99% |
| Application | For research purpose only |
| Packing | 25kg/drum |
| Storage | Store in a well-closed,light-resistant container |
| Remarks | NA |
| Custom synthesis | Available |
){kind=link}